Nirman Agri Genetics
- P/E
- 0.74
Key Fundamentals
SMEConsumer GoodsFMCGPrice-based figures as of · TTM
- ROCE
- 15.20%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹33.50
- Book Value
- ₹159.24
- Market Cap
- —
- P/E (TTM)
- 0.74
- P/B
- 0.16
- ROE
- 14.80%
- Dividend Yield
- 8.33%
- EBITDA
- ₹18.80 Cr
- 52W High
- ₹81.55
- 52W Low
- ₹22.00
- Day Range
- ₹23.85 – ₹25.20
- Volume
- 7,800
Peer Comparison
Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products
| ₹410.10 | 22.24 | ₹14,281 Cr | 2.91 | 0.73% | 14.70% | 17.60% | ₹11,633 Cr | ₹640 Cr | |
| ₹408.65 | 12.33 | ₹9,318 Cr | 1.50 | 1.12% | 11.70% | 15.20% | ₹6,009 Cr | ₹758 Cr | |
| ₹152.09 | 16.77 | ₹6,847 Cr | 1.94 | 0.20% | 9.72% | 12.50% | ₹6,032 Cr | ₹416 Cr | |
| ₹680.25 | 14.02 | ₹3,469 Cr | 1.73 | 0.75% | 15.00% | 15.80% | ₹1,279 Cr | ₹249 Cr | |
| ₹369.45 | 20.27 | ₹3,167 Cr | 1.96 | 0.00% | 8.38% | 10.40% | ₹2,050 Cr | ₹159 Cr | |
| ₹222.57 | 15.79 | ₹2,241 Cr | 2.33 | 0.00% | 15.80% | 15.70% | ₹2,627 Cr | ₹132 Cr | |
| ₹92.98 | 23.84 | ₹1,926 Cr | 3.21 | 0.48% | 14.20% | 14.00% | ₹1,869 Cr | ₹77 Cr | |
| ₹24.90 | 0.74 | ₹19 Cr | 0.16 | 8.33% | 14.80% | 15.20% | ₹237 Cr | ₹25 Cr | |
| Median 8 companies | ₹296.01 | 16.28 | ₹3,318 Cr | 1.95 | 0.61% | 14.45% | 15.20% | ₹2,338 Cr | ₹204 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 60
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 75
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 18
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 4
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
5- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.16 times its book value
- Company is expected to give good quarter
- Company has delivered good profit growth of 223% CAGR over last 5 years
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Debtor days have increased from 84.6 to 129 days.
- Promoter holding has decreased over last 3 years: -21.7%
- Working capital days have increased from 133 days to 213 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 7 | 3 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Neutral
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.91
- Neutral
- MACD (12,26,9)
- −0.92
- Bullish
- SMA (50)
- 26.85
- Bearish
- SMA (200)
- 42.20
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | Irregular period |
|---|---|
| 3Y | +89.39% |
| 1Y | −16.88% |
Net profit
| 5Y | Irregular period |
|---|---|
| 3Y | +65.10% |
| 1Y | −28.00% |
Operating cash flow
| 5Y | Irregular period |
|---|---|
| 3Y | Turned negative |
| 1Y | Outflow narrowed by ₹8 Cr |
Operating margin· change in pp
| 5Y | Irregular period |
|---|---|
| 3Y | −4.15 pp |
| 1Y | −1.75 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2022 | ₹13.00 Cr |
|---|---|
| Mar 2023 | ₹29.00 Cr |
| Mar 2024 | ₹63.00 Cr |
| Mar 2025 | ₹237 Cr |
| Mar 2026 | ₹197 Cr |
Net profit by year
| Mar 2022 | ₹3.00 Cr |
|---|---|
| Mar 2023 | ₹4.00 Cr |
| Mar 2024 | ₹10.00 Cr |
| Mar 2025 | ₹25.00 Cr |
| Mar 2026 | ₹18.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 6 | 14 | 24 | 39 | 112 | 124 | 146 | 50 |
| Expenses | 4 | 11 | 20 | 33 | 100 | 110 | 131 | 47 |
| Operating Profit | 2 | 3 | 4 | 7 | 12 | 15 | 15 | 4 |
| OPM % | 27% | 20% | 19% | 17% | 11% | 12% | 10% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| PBT | 2 | 3 | 4 | 7 | 12 | 14 | 15 | 3 |
| Tax % | 0% | 10% | 10% | 2% | 4% | 3% | 3% | 3% |
| Net Profit | 2 | 2 | 4 | 6 | 11 | 14 | 15 | 3 |
| EPS (₹) | — | 2.96 | 4.91 | 8.1 | 14.3 | 17.04 | 18.2 | 3.78 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 4 | 13 | 29 | 63 | 237 | 197 |
| Expenses | 4 | 10 | 24 | 52 | 210 | 178 |
| Operating Profit | 0 | 3 | 4 | 11 | 27 | 19 |
| OPM % | 1.8% | 25% | 15% | 18% | 11% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 |
| PBT | 0 | 3 | 4 | 11 | 26 | 18 |
| Tax % | 29% | 25% | 6% | 5% | 3% | 3% |
| Net Profit | 0 | 3 | 4 | 10 | 25 | 18 |
| EPS (₹) | — | — | 5.01 | 13 | 31.57 | 21.99 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 6 | 6 | 8 | 8 |
| Reserves | 0 | 3 | 21 | 31 | 102 | 120 |
| Borrowings | 1 | 1 | 1 | 1 | 0 | 0 |
| Other Liabilities | 1 | 2 | 2 | 6 | 3 | 2 |
| Total Liabilities | 2 | 6 | 30 | 44 | 113 | 129 |
| Fixed Assets | 0 | 0 | 1 | 0 | 2 | 2 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2 | 6 | 29 | 44 | 111 | 128 |
| Total Assets | 2 | 6 | 30 | 44 | 113 | 129 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | 0 | 0 | 4 | −32 | −24 |
| Investing | 0 | 0 | −21 | −2 | 10 | 0 |
| Financing | 1 | 0 | 20 | −1 | 46 | −1 |
| Net Cash Flow | 1 | 0 | −1 | 1 | 24 | −25 |
| Free Cash Flow | 0 | 0 | −1 | 4 | −33 | −25 |
| CFO/EBITDA | −357 | 25 | 2 | 36 | −119 | −130 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 58 | 114 | 52 | 67 | 58 | 129 |
| Inventory Days | 21 | 25 | 76 | 61 | — | — |
| Days Payable | 40 | 38 | 6 | 39 | — | — |
| Cash Conversion Cycle | 39 | 101 | 121 | 89 | 58 | 129 |
| Working Capital Days | 32 | 76 | 87 | 76 | 110 | 213 |
| ROCE % | — | 133% | 27% | 34% | 35% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nirman Agri Genetics insights
54 extracted metrics across FY21–FY26.
Documents
- 19 Oct 2026
- 1 Oct 2026
- 30 Sep 2026
- 30 Sep 2026
Frequently Asked Questions about Nirman Agri Genetics
What does Nirman Agri Genetics Ltd do?
Where is Nirman Agri Genetics Ltd (NIRMAN) listed?
Which sector does Nirman Agri Genetics Ltd belong to?
What is the PE ratio of Nirman Agri Genetics Ltd?
What is the 52-week high and low of Nirman Agri Genetics Ltd?
Does Nirman Agri Genetics Ltd pay dividends?
What is the Return on Equity (ROE) of Nirman Agri Genetics Ltd?
Company Information
Incorporated in 2020, Nirman Agri Genetics Ltd is in the business of manufacturing and processing seeds
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NIRMAN.md for Nirman Agri Genetics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.